Extending the Spectrum of Precompetitive Collaboration in Oncology Research

Publisher : National Academies Press

ISBN-13 : 0309156548

Page : 112 pages

Rating : 4.5/5 from 548 voters

Despite spending more time and money in developing novel therapeutics, the success rate for new pharmacologic treatments has been poor. Although the research and development expenditures have grown 13 percent each year since 1970 (a 50-fold increase), the number of new drugs approved annually is no greater now than it was 50 years ago. Over the past decade, skyrocketing costs and the complexity of the scientific knowledge upon which to develop new agents have provided incentives for alternative approaches to drug development, if we are to continue to improve clinical care and reduce mortality. These challenges create opportunities for improved collaboration between industry, academia, government, and philanthropic organizations at each stage in new drug development, marketing, and implementation. Perhaps the most appropriate initial step in addressing the need for collaboration is to consider more precompetitive relationships that allow sharing of scientific information to foster drug development. While these collaborative relationships in basic and preclinical research on drug targets and the early stages of clinical testing are acknowledged to be potentially important drivers for innovation and more rapid marketing of new agents, they also raise a number of concerns that must be addressed. For example, acknowledgment of academic productivity and independence and economic competitiveness must be considered and these challenges managed to foster a culture of collaboration. At the same time, regulatory issues, the need for standardization, and intellectual property concerns must be confronted if the current models for drug development are to be refined to encourage robust participation in precompetitive collaborations. Recognizing the growing importance of precompetitive collaborations in oncology drug development, as well as the challenges these innovative collaborations pose, the National Cancer Policy Forum of the Institute of Medicine held a workshop on February 9 and 10, 2010. This book is a summary of the workshop proceedings.

More Books:

Extending the Spectrum of Precompetitive Collaboration in Oncology Research
Language: en
Pages: 112
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2010-10-15 - Publisher: National Academies Press

Despite spending more time and money in developing novel therapeutics, the success rate for new pharmacologic treatments has been poor. Although the research an
Extending the Spectrum of Precompetitive Collaboration in Oncology Research
Language: en
Pages: 112
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2010-09-15 - Publisher: National Academies Press

Despite spending more time and money in developing novel therapeutics, the success rate for new pharmacologic treatments has been poor. Although the research an
Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development
Language: en
Pages: 90
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2011-02-17 - Publisher: National Academies Press

Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to b
Facilitating Collaborations to Develop Combination Investigational Cancer Therapies
Language: en
Pages: 118
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2012-02-06 - Publisher: National Academies Press

Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in
Principles and Practice of Clinical Research
Language: en
Pages: 780
Authors: John I. Gallin
Categories: Medical
Type: BOOK - Published: 2012 - Publisher: Academic Press

This expanded third edition provides an introduction to the conduct of clinical research as well as more comprehensive and expansive content about the infrastru
Phytotherapies
Language: en
Pages: 672
Authors: Iqbal Ramzan
Categories: Medical
Type: BOOK - Published: 2015-04-17 - Publisher: John Wiley & Sons

Covering fundamentals and new developments in phytotherapy, this book combines pharmaceutical sciences and chemistry with clinical issues. • Helps readers bet
Improving the Utility and Translation of Animal Models for Nervous System Disorders
Language: en
Pages: 110
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2013-03-25 - Publisher: National Academies Press

Nervous system diseases and disorders are highly prevalent and substantially contribute to the overall disease burden. Despite significant information provided
Genomic and Personalized Medicine
Language: en
Pages: 1350
Authors:
Categories: Science
Type: BOOK - Published: 2012-10-30 - Publisher: Academic Press

Genomic and Personalized Medicine, Second Edition — winner of a 2013 Highly Commended BMA Medical Book Award for Medicine — is a major discussion of the str
A National Cancer Clinical Trials System for the 21st Century
Language: en
Pages: 316
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2010-08-08 - Publisher: National Academies Press

The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However,
Accelerating Successes Against Cancer
Language: en
Pages: 124
Authors:
Categories: Cancer
Type: BOOK - Published: 2006 - Publisher: